Benoit Lechartier

1   Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France

2   School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

3   INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies,” Hôpital Marie Lannelongue, Le Plessis-Robinson, France

4   Respiratory Division, Lausanne University Hospital (CHUV), Lausanne, Switzerland

,

Mithum Kularatne

1   Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France

2   School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

3   INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies,” Hôpital Marie Lannelongue, Le Plessis-Robinson, France

5   Division of Respiratory Medicine, Department of Medicine, University of Calgary, Canada

,

Xavier Jaïs

1   Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France

2   School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

3   INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies,” Hôpital Marie Lannelongue, Le Plessis-Robinson, France

6   European Reference Network on Rare Pulmonary Diseases (ERN-LUNG)

,

Marc Humbert

1   Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France

2   School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

3   INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies,” Hôpital Marie Lannelongue, Le Plessis-Robinson, France

6   European Reference Network on Rare Pulmonary Diseases (ERN-LUNG)

,

David Montani

1   Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France

2   School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France

3   INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies,” Hôpital Marie Lannelongue, Le Plessis-Robinson, France

6   European Reference Network on Rare Pulmonary Diseases (ERN-LUNG)